Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
Cronos Group (NASDAQ: CRON) announced the results of its 2025 Annual Meeting of Shareholders, with a 71.87% shareholder participation representing 276,989,452 common shares. All nominated directors were successfully elected with over 92.3% approval rates. Notably, shareholders approved the executive compensation advisory resolution with 94.13% support and confirmed Davidson & Company LLP as the independent auditor for fiscal year 2025.
The board election saw strong support for all directors, with Dominik Meier receiving the highest approval at 96.94%, followed by Kamran Khan at 96.92%. Michael Gorenstein received 92.38% of votes in favor, representing the lowest but still overwhelmingly positive support among the directors.
Cronos Group (NASDAQ: CRON) ha annunciato i risultati della sua Assemblea Annuale degli Azionisti 2025, con una partecipazione degli azionisti del 71,87%, pari a 276.989.452 azioni ordinarie. Tutti i direttori nominati sono stati eletti con successo con tassi di approvazione superiori al 92,3%. In particolare, gli azionisti hanno approvato la risoluzione consultiva sulla remunerazione degli executive con un 94,13% di supporto e hanno confermato Davidson & Company LLP come revisore indipendente per l'anno fiscale 2025.
L'elezione del consiglio ha ricevuto un forte sostegno da parte di tutti i direttori, con Dominik Meier che ha ottenuto il più alto tasso di approvazione al 96,94%, seguito da Kamran Khan con il 96,92%. Michael Gorenstein ha ricevuto il 92,38% dei voti favorevoli, rappresentando il supporto più basso ma comunque ampiamente positivo tra i direttori.
Cronos Group (NASDAQ: CRON) anunció los resultados de su Reunión Anual de Accionistas 2025, con una participación accionaria del 71,87%, representando 276,989,452 acciones ordinarias. Todos los directores nominados fueron elegidos con éxito con tasas de aprobación superiores al 92,3%. Destaca que los accionistas aprobaron la resolución consultiva sobre la compensación ejecutiva con un 94,13% de apoyo y confirmaron a Davidson & Company LLP como auditor independiente para el año fiscal 2025.
La elección de la junta recibió un fuerte respaldo para todos los directores, con Dominik Meier obteniendo la mayor aprobación con un 96,94%, seguido de Kamran Khan con un 96,92%. Michael Gorenstein recibió el 92,38% de los votos a favor, siendo el apoyo más bajo pero aún así abrumadoramente positivo entre los directores.
Cronos Group (NASDAQ: CRON)는 2025년 주주 총회 결과를 발표했으며, 71.87%의 주주 참여율로 276,989,452주의 보통주가 대표되었습니다. 지명된 모든 이사는 92.3% 이상의 승인률로 성공적으로 선출되었습니다. 특히, 주주들은 경영진 보상에 관한 자문 결의안을 94.13%의 지지로 승인했으며, 2025 회계연도 독립 감사인으로 Davidson & Company LLP를 재확인했습니다.
이사회 선거에서는 모든 이사에 대한 강력한 지지가 있었으며, Dominik Meier가 96.94%로 가장 높은 승인율을 받았고, 그 다음으로 Kamran Khan이 96.92%를 받았습니다. Michael Gorenstein은 92.38%의 찬성표를 받아 이사들 중 가장 낮았지만 여전히 압도적으로 긍정적인 지지를 받았습니다.
Cronos Group (NASDAQ : CRON) a annoncé les résultats de son Assemblée Générale Annuelle des actionnaires 2025, avec une participation des actionnaires de 71,87%, représentant 276 989 452 actions ordinaires. Tous les administrateurs nominés ont été élus avec succès avec des taux d'approbation supérieurs à 92,3%. Notamment, les actionnaires ont approuvé la résolution consultative sur la rémunération des dirigeants avec un soutien de 94,13% et ont confirmé Davidson & Company LLP en tant qu'auditeur indépendant pour l'exercice 2025.
L'élection du conseil d'administration a bénéficié d'un fort soutien pour tous les administrateurs, Dominik Meier obtenant la plus haute approbation avec 96,94%, suivi de Kamran Khan avec 96,92%. Michael Gorenstein a reçu 92,38% des voix favorables, représentant le soutien le plus faible mais néanmoins largement positif parmi les administrateurs.
Cronos Group (NASDAQ: CRON) gab die Ergebnisse seiner Hauptversammlung 2025 bekannt, mit einer Aktionärsbeteiligung von 71,87%, was 276.989.452 Stammaktien entspricht. Alle nominierten Direktoren wurden mit über 92,3% Zustimmung erfolgreich gewählt. Bemerkenswert ist, dass die Aktionäre die beratende Entschließung zur Vorstandsvergütung mit 94,13% Unterstützung genehmigten und Davidson & Company LLP als unabhängigen Wirtschaftsprüfer für das Geschäftsjahr 2025 bestätigten.
Die Wahl des Vorstands erhielt starke Unterstützung für alle Direktoren, wobei Dominik Meier die höchste Zustimmung mit 96,94% erhielt, gefolgt von Kamran Khan mit 96,92%. Michael Gorenstein erhielt 92,38% der Stimmen, was die niedrigste, aber dennoch überwältigend positive Unterstützung unter den Direktoren darstellt.
- None.
- None.
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing
Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of
| Name of Director | Number of Shares Voted For | Percentage of Shares Voted For | Number of Shares Withheld from Voting | Percentage of Shares Withheld from Voting |
| Michael Gorenstein | 206,219,875 | 17,012,443 | ||
| Jason Adler | 215,665,946 | 7,566,372 | ||
| Murray Garnick | 215,548,312 | 7,684,006 | ||
| Kamran Khan | 216,349,694 | 6,882,624 | ||
| Dominik Meier | 216,404,347 | 6,827,971 | ||
| Elizabeth Seegar | 211,177,232 | 12,055,086 | ||
| James Rudyk | 215,956,203 | 7,276,115 |
Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company’s named executive officers, with
For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at www.sedarplus.com and the Company’s Form 8-K filed on EDGAR at www.sec.gov/edgar.
About Cronos
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
For further information, please contact:
Harrison Aaron
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com
FAQ
What was the voter turnout at Cronos Group's (CRON) 2025 Annual Meeting?
Who received the highest approval rating among Cronos (CRON) directors in the 2025 election?
What was the voting result for Cronos Group's (CRON) executive compensation resolution in 2025?
Who was appointed as Cronos Group's (CRON) independent auditor for fiscal year 2025?
